Hubei Guangji Pharmaceutical Co. Ltd

Hubei Guangji Pharmaceutical Co., Ltd. (hereinafter referred to as "Guangji Pharmaceutical") was established in 1969 and listed on the Shenzhen Stock Exchange in 1999. It is a state-owned technology enterprise with a history of 54 years and the only provincial pharmaceutical listed company in Hubei Province. , Yangtze River Industrial Investment Group is the company’s controlling shareholder. Guangji Pharmaceutical mainly produces vitamins B2, B6, B12, iso-VC sodium, lactic acid and lactate series products, gluconic acid series products, starch series products and pharmaceutical preparation products. It is the world's major vitamin B2 product supplier and technology enterprise. , a hidden champion in the pillar industry subdivisions of Hubei Province, a specialized and new little giant, and one of the first batch of cloud companies. The company has established two research institutes in Optics Valley, Wuhan. It is one of the few modern pharmaceutical companies in China that combines "biological fermentation" and "chemical synthesis" technologies and has outstanding advantages in biological fermentation. The company is currently vigorously promoting technological innovation and striving to achieve strategic transformation from a production and manufacturing enterprise to an innovation-led enterprise. The company will adhere to the development strategy of "endogenous expansion + platform development + strong and complementary chain mergers and acquisitions", follow the "one platform, two bases" industrial layout, build a scientific and technological innovation research and development platform, and create two major industrialization bases of biological fermentation and chemical synthesis. . Horizontally expand the product pipeline in the three major areas of pharmaceutical raw materials and preparations, high value-added nutritional additives, and bio-based materials, and vertically extend the downstream industrial chain in accordance with the "API + Preparation + Big Health" product strategy to form a criss-crossed three-dimensional product pattern , and strive to become a "leading" bio-fermentation enterprise with world influence and domestic benchmarking.